↓ Skip to main content

Dove Medical Press

Article Metrics

Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics.

Overview of attention for article published in Pharmgenomics Pers Med, December 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
30 Mendeley
Title
Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics.
Published in
Pharmgenomics Pers Med, December 2014
DOI 10.2147/pgpm.s52821
Pubmed ID
Authors

Agarwal A, Soliman MK, Sepah YJ, Do DV, Nguyen QD

Abstract

Diabetes and its microvascular complications in patients poses a significant challenge and constitutes a major health problem. When it comes to manifestations in the eye, each case of diabetic retinopathy (DR) is unique, in terms of the phenotype, genotype, and, more importantly, the therapeutic response. It is therefore important to identify factors that distinguish one patient from another. Personalized therapy in DR is a new trend aimed at achieving maximum therapeutic response in patients by identifying genotypic and phenotypic factors that may result in less than optimal response to conventional therapy, and consequently, lead to poorer outcome. With advances in the identification of these genetic markers, such as gene polymorphisms and human leucocyte antigen associations, as well as development of drugs that can target their effects, the future of personalized medicine in DR is promising. In this comprehensive review, data from various studies have been analyzed to present what has been achieved in the field of pharmacogenomics thus far. An insight into future research is also provided.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Pakistan 1 3%
Unknown 29 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 27%
Student > Bachelor 5 17%
Unspecified 3 10%
Professor > Associate Professor 3 10%
Student > Doctoral Student 3 10%
Other 8 27%
Readers by discipline Count As %
Medicine and Dentistry 7 23%
Agricultural and Biological Sciences 7 23%
Unspecified 4 13%
Neuroscience 3 10%
Biochemistry, Genetics and Molecular Biology 2 7%
Other 7 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 January 2015.
All research outputs
#2,526,819
of 4,759,395 outputs
Outputs from Pharmgenomics Pers Med
#4
of 4 outputs
Outputs of similar age
#86,908
of 167,890 outputs
Outputs of similar age from Pharmgenomics Pers Med
#164
of 466 outputs
Altmetric has tracked 4,759,395 research outputs across all sources so far. This one is in the 33rd percentile – i.e., 33% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4 research outputs from this source. They receive a mean Attention Score of 0.2. This one scored the same or higher as 0 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 167,890 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 466 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.